SOM Biotech Concludes 2020 with Advanced and Robust Pipeline
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment...
The current Covid-19 pandemic situation has shown that repurposing drugs can be crucial for delivering new treatments to patients with agility. Existing drugs can be developed to bring fast, safe and cost-effective treatments for a wide range of conditions. The improved use of data and the development of advanced AI-based technologies enable the fast and effective identification of drugs, accelerating drug discovery, repurposing and innovation.
SOM Biotech works with a proprietary ligand-based in-silico platform, SOMAI PRO that has proven to be an outstanding tool to successfully identify drugs with similar or better biological activity compared to a reference compound acting on a disease-related target. The drug discovery approach is fundamentally based on molecular structures, and particularly on their structural and physicochemical properties – the “molecular fields” (MFs).
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment...
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment...
SOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of...
Unique advantages of SOMAI PRO include identification of new mechanisms of action of drugs (biological...